Loading clinical trials...
Loading clinical trials...
People with psychosis have significantly higher rates of adversity (e.g., abuse) and substance misuse (i.e., problematic drug and alcohol use) than people with other mental illnesses. Research has fou...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Nova Scotia Health Authority
Collaborators
NCT06929520 · E-cigarette Use, Substance Use
NCT07146633 · Posttraumatic Stress Disorder (PTSD), Substance Use Disorders
NCT06889831 · Substance Use Disorder (SUD), Sexual and Reproductive Health, and more
NCT06743711 · Severe Mental Illness, Schizophrenia Spectrum &Amp; Other Psychotic Disorders, and more
NCT06790641 · Perinatal Anxiety, Perinatal Depression, and more
Nova Scotia Early Psychosis Program (NSEPP), Abbie J. Lane Memorial Building
Halifax, Nova Scotia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions